(Q34866838)

English

A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

0 references

placebo-controlled trial

1 reference

based on heuristic

inferred from title

author name string

Sallie B Cosgrove

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Jody A Wren

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Dawn M Cleaver

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Kelly F Walsh

4

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Stacey I Follis

5

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Vickie I King

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Jezaniah-Kira S Tena

7

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Michael R Stegemann

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

publication date

1 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Veterinary Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

587-97, e141-2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4286885

8 July 2018

Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4286885

8 July 2018

A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008-2011 update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4286885

8 July 2018

Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4286885

8 July 2018

Inconsistent definitions for intention-to-treat in relation to missing outcome data: systematic review of the methods literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4286885

8 July 2018

A modular view of cytokine networks in atopic dermatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4286885

8 July 2018

Development of a questionnaire to assess the impact of atopic dermatitis on health-related quality of life of affected dogs and their owners

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4286885

8 July 2018

Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4286885

8 July 2018

Janus kinases in immune cell signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4286885

8 July 2018

Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4286885

8 July 2018

Immune dysregulation in atopic dermatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4286885

8 July 2018

Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4286885

8 July 2018

The ACVD task force on canine atopic dermatitis (XX): glucocorticoid pharmacotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4286885

8 July 2018

The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in clinical diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4286885

8 July 2018

The ACVD task force on canine atopic dermatitis (XIV): clinical manifestations of canine atopic dermatitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4286885

8 July 2018

Revised nomenclature for veterinary allergy.

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12088

21 January 2018

Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12088

21 January 2018

Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12088

21 January 2018

Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12088

21 January 2018

Randomized controlled trial of the efficacy of cyclosporine in the treatment of atopic dermatitis in dogs

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12088

21 January 2018

Further validation of a pruritus severity scale for use in dogs

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12088

21 January 2018

Comparison of cyclosporine A with methylprednisolone for treatment of canine atopic dermatitis: a parallel, blinded, randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12088

21 January 2018

The use of recombinant omega interferon therapy in canine atopic dermatitis: a double-blind controlled study

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12088

21 January 2018

Health status and population characteristics of dogs and cats examined at private veterinary practices in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/24581322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24581322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current understanding of the pathophysiologic mechanisms of canine atopic dermatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24581322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/VDE.12088

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

release_xxlljz3ecze4vop7v3hiwxwyl4

1 reference

https://api.fatcat.wiki/v0/release/xxlljz3ecze4vop7v3hiwxwyl4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34866838&oldid=1843420131"